Department of Pharmaceutical Chemistry

Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?

Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research, from a team at UCSF and Gladstone Institutes that includes School of Pharmacy researchers, has stalled since the grant was cut.

The Science of Smell: Q&A with Aashish Manglik, MD, PhD

We asked the Department of Pharmaceutical Chemistry associate professor how helping to uncover the fundamental principles of our smell perception could improve understanding of how other proteins in the body recognize small molecules, including potential new drugs.

Koda-Kimble Seed Award Fuels 11 Innovative Projects

Eleven innovative projects with the potential to further the mission of the UCSF School of Pharmacy in new ways will garner a financial boost from the 2025 Mary Anne Koda-Kimble Seed Award for Innovation.

Decoding COVID-19: QBI Researchers Pave the Way for New Drug Discoveries to Combat Virus

The QBI Coronavirus Research Group (QCRG) fast-tracked antiviral drug discovery by partnering with scientists around the globe and around the clock, deepening understanding of how viruses attack cells and shaping the future of pandemic preparedness.

Lessons Learned: Five Years of COVID-19 Research and Response at UCSF

UCSF School of Pharmacy experts share their perspectives on the lessons learned from the pandemic and the evolving role of pharmacy in strengthening public health, advancing scientific discovery and preparing for future global challenges.

UCSF School of Pharmacy Leads in NIH Funding for 45th Consecutive Year

The UCSF School of Pharmacy continues to lead the country in competitive federal research funding among pharmacy schools, capturing $45.8 million in 2024 to fuel life-changing drug discoveries, bioengineering, pharmacokinetics and more.

Craik and UCSF Team Take Significant Step Toward Patient-Specific Radiation Therapies

A new therapy combines a drug to mark cancer cells for destruction and a radioactive antibody to kill them, while calculating an extremely safe dose of radiation that uses only the amount of radiation needed to beat the cancer.

Using AI to Make Precision Medicine More Accessible

Emily A. Hammad Mrig, PhD, is using natural language processing (NLP) to identify patients and solutions that make molecular diagnostics more affordable and equitable.

School of Pharmacy faculty recognized among Highly Cited Researchers

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

Pages